ATP citrate lyase drives vascular remodeling in systemic and pulmonary vascular diseases through metabolic and epigenetic changesYann Grobs, Sébastien Bonnet, Alice Bourgeois et al.|Science Translational Medicine|2024Cited by 33
Exploring Integrin α5β1 as a Potential Therapeutic Target for Pulmonary Arterial Hypertension: Insights From Comprehensive Multicenter Preclinical StudiesSarah‐Eve Lemay, Sébastien Bonnet, Charlie Théberge et al.|Circulation|2025Cited by 26
Unraveling AURKB as a potential therapeutic target in pulmonary hypertension using integrated transcriptomic analysis and pre-clinical studiesSarah‐Eve Lemay, Olivier Boucherat, Mónica S. Montesinos et al.|Cell Reports Medicine|2025Cited by 8
Exploratory Study of Prognostic Plasma Biomarkers in Patients with Pulmonary Arterial HypertensionYukimitsu Kuwabara, Olivier Boucherat, Tetsuro Yokokawa et al.|American Journal Of Pathology|2025Cited by 2
Integrin α5β1: a promising target for right ventricular dysfunction in pulmonary arterial hypertensionSarah‐Eve Lemay, Sébastien Bonnet, Yann Grobs et al.|Unknown|2025Cited by 1